Treatment of Nephrogenic Diabetes Insipidus Patients With cGMP-Stimulating Drugs Does Not Mitigate Polyuria or Increase Urinary Concentrating Ability

por Hinrichs, Gitte R., Mortensen, Line A., Bistrup, Claus, Dieperink, Hans H., Jensen, Boye L.
Publicado 2020

Real-world costs of autosomal dominant polycystic kidney disease in the Nordics

por Eriksson, Daniel, Karlsson, Linda, Eklund, Oskar, Dieperink, Hans, Honkanen, Eero, Melin, Jan, Selvig, Kristian, Lundberg, Johan
Publicado 2017

Health-related quality of life across all stages of autosomal dominant polycystic kidney disease

por Eriksson, Daniel, Karlsson, Linda, Eklund, Oskar, Dieperink, Hans, Honkanen, Eero, Melin, Jan, Selvig, Kristian, Lundberg, Johan
Publicado 2017

A novel mutation affecting the arginine‐137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin‐2

por Hinrichs, Gitte R., Hansen, Louise H., Nielsen, Maria R., Fagerberg, Christina, Dieperink, Hans, Rittig, Søren, Jensen, Boye L.
Publicado 2016